Education
About Us
Working with TipRanks
Follow Us
Orthofix International N.V. (OFIX)
NASDAQ:OFIX
Earnings Data
Report Date
Aug 12, 2025TBA Not Confirmed
Period Ending
2025 (Q2)Consensus EPS Forecast
-0.4Last Year’s EPS
-0.88Same Quarter Last Year
Strong Buy
Based on 4 Analysts Ratings
Earnings Call Summary
Earnings Call Date:May 06, 2025
|% Change Since: -23.56%
|Next Earnings Date:Aug 12, 2025
Earnings Call Sentiment|Neutral
Orthofix's first quarter earnings call highlighted several positive developments, including revenue growth, EBITDA margin expansion, and strong performances in Bone Growth Therapies and Orthopedics. However, challenges such as spine business softness, pricing pressures, and the impact of the M6 discontinuation were noted. Overall, while the company is making significant strides in various areas, the balance of positive and negative elements suggests a stable outlook with ongoing challenges to address.Company Guidance
During the Orthofix First Quarter 2025 Earnings Call, the company provided a comprehensive overview of its performance and financial guidance for the year. Orthofix reported first-quarter pro forma net sales of $189.2 million, representing a year-over-year constant currency growth of 6% on a same sales day basis. This growth was driven by a 5.4% increase in the US spinal fixation business and a 7% rise in Bone Growth Therapies (BGT) net sales. The company also highlighted a 13% growth in its Global Orthopedic business. For the full year 2025, Orthofix expects net sales to range between $808 million and $816 million, excluding the discontinued M6 product lines, implying a 5% growth at the midpoint. The company also anticipates full-year non-GAAP adjusted EBITDA between $82 million and $86 million, reflecting a 190 basis-point margin expansion compared to 2024. Challenges such as the discontinuation of M6 artificial discs and distributor transitions were noted, but Orthofix remains focused on strategic priorities to drive long-term shareholder value.Revenue Growth
First quarter pro forma net sales of $189.2 million represent year-over-year constant currency growth of 6%.
Adjusted EBITDA Margin Expansion
Delivered another quarter of excellent progress in adjusted EBITDA margin expansion that exceeded expectations.
Bone Growth Therapies Performance
Bone Growth Therapies net sales grew 7% overall and 8% in the fracture market with AccelStim bone growth therapy device continuing to outperform the market.
Orthopedics Business Growth
Global Orthopedics business delivered a constant-currency growth of 13% on a same sales day basis in Q1.
FDA Approval for AccelStim 2.0
Received earlier than anticipated FDA approval for AccelStim 2.0, reinforcing market leadership in bone growth simulation.
TrueLok Elevate TBT System Success
Over 90 TrueLok elevated cases completed with overwhelmingly positive responses from surgeons.
OFIX Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
OFIX Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
May 06, 2025 | $13.54 | $12.06 | -10.93% |
Feb 25, 2025 | $18.15 | $17.51 | -3.53% |
Nov 07, 2024 | $18.40 | $18.22 | -0.98% |
Aug 06, 2024 | $14.59 | $17.44 | +19.53% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Orthofix International N.V. (OFIX) report earnings?
Orthofix International N.V. (OFIX) is schdueled to report earning on Aug 12, 2025, TBA Not Confirmed.
What is Orthofix International N.V. (OFIX) earnings time?
Orthofix International N.V. (OFIX) earnings time is at Aug 12, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is OFIX EPS forecast?
OFIX EPS forecast for the fiscal quarter 2025 (Q2) is -0.4.